Last updated on May 18th, 2021 at 05:44 am
China is willing to collaborate with the Southeast Asian region in the research and development of vaccine for the COVID19, Chinese ambassador to Asean Deng Xi Jun confirmed on Saturday (June 13).
Since the outbreak of Covid-19, both sides shared multiple anti-pandemic cooperation pushing for regional consensus on a stronger collective response while boosting trade in the region.
The ambassador also said that China has always considered Asean as friendly neighbors that has the tradition of mutual support and help. This health crisis just shows the sound cooperation between the two in the fight against Covid-19.
China also sees the cooperation with Asean as a great potential in term of production and development of the vaccine. It is currently being developed in five categories – inactivated, recombinant protein, live attenuated influenza, adenovirus and nucleic acid-based vaccines.
The diplomat added that currently, four inactivated and one adenovirus vaccine have been approved for clinical trials.
“China leads the world in certain technological approaches to the vaccines.” he added The ambassador reiterated that Covid-19 vaccine, once available in China will be made a global public good .
BLACKPINK's Jennie made a defining moment in her solo career by breaking the record for most album units sold in…
China tests its expanding military abilities by holding major amphibious landings in the South China Sea because tensions in the…
Singapore and Thailand marked 60 years of diplomatic relations with the signing of five major Memorandums of Understanding (MOUs) on…
Indian Formula 1 supporters gained their initial chance to watch F1 racing in their native languages including Hindi delivered by…
From the Avengers: Endgame directors Joe and Anthony Russo, be prepared for an enjoyable sci-fi adventure with the entry of…
India remains behind other countries when it comes to offering affordable CAR T-cell therapy although this treatment uses modified immune…
This website uses cookies.
Read More
View Comments